Nabriva Therapeutics plc
NBRVF0.00010.00% ( 0.0000 )
Q2 FY2023 Earnings
Financial report interval: 2023.03.30 - 2023.06.30
Overview: Nabriva Therapeutics plc(NBRVF) the Revenue is 2.243 M (-75.6%);the EBIT is -12.02 M (-15.63%);the EPS is -3.73 (+14.72%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B75.60%
----
----
EBIT
-0.01B15.63%
----
----
EPS
-3.733414.72%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf